Plasma Derived Medicine Market Key Highlights:
- Market Size (2024): USD 35.21 Billion
- Projected Market Size (2034): USD 73.24 Billion
- CAGR (2023-2034): 7.6%
Pricing Analysis:
- Price Growth
- Regional Variations
Market Historic Sales
- Total sales volume, year-over-year growth, product categories, and market share.
Revenue Estimation
- Forecasting future revenues based on historical data, market trends, and economic indicators.
Sales by Region
- Breakdown of sales performance across different geographical areas.
Revenue by Manufacturer
- Analysis of revenue contributions from different manufacturers in the market.
Plasma Derived Medicine Market Definition
The Plasma-Derived Medicine Market is an important component of the healthcare industry that offers solutions to patients with serious health conditions where there is inadequate health care. It is expanding across all regions of the globe due to advances in collection techniques, production processes, and therapeutic applications. The plasma products market is witnessing rapid growth due to the increasing number of life-threatening illnesses and the growing need for plasma products especially for rare disease management. These drugs play an important role in diseases such as primary immunodeficiencies, blood disorders, and some other conditions characterized by the necessity of replacement of clotting factors.
The increasing number of patients diagnosed with rare diseases and awareness regarding their clinical aspects and treatment drive the growth of the market. The increasing life expectancy of patients with rare and intricate conditions has led to an increase in the population of patients who need long-term plasma infusions. For patients, the regulators relaxed the approval processes, plus offered a time bar on competition for specific categories of drugs termed orphan drugs, thereby pushing pharmaceutical companies to explore the market gaps.
Plasma Derived Medicine Market Segmentation:
By Type
- Albumin
- Immune Globulin
- Coagulation Factor
- Others
By Application
- Hospital
- Retail Pharmacy
- Other
Plasma Derived Medicine Market Companies:
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Tiantan Bio
- Shuanglin Bio
- Boya Bio
- Yuanda Shuyang
- Weiguang Bio
- Nanyue Bio
- KM Biologics.
For any questions about this dataset or to discuss customization options, please write to us at sales@statifacts.com
